![Paul Manning](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Manning
Chairman at
CANDEL THERAPEUTICS, INC.
Net worth: 561 M $ as of 2026-05-30
Profile
Paul B. Manning is the founder.
Mr. Manning was the founder of PBM Products LLC, serving as President & Chief Executive Officer since 1997.
Mr. Manning is the founder of PBM Capital Group LLC, serving as Chairman and CEO since 2010.
Mr. Manning is also the founder of Able Laboratories, Inc. Mr. Manning serves as President & Chief Executive Officer at PBM Capital Investments LLC.
Mr. Manning serves as Chairman at Candel Therapeutics, Inc. since 2021.
Mr. Manning serves as Chairman at Xalud Therapeutics, Inc. Mr. Manning serves as Chairman at Verrica Pharmaceuticals, Inc. since 2017.
Mr. Manning serves as Director at PatientsLikeMe LLC since 2022.
Mr. Manning serves as Director at The Foundation Fighting Blindness, Inc. Mr. Manning serves as Director at Foundation Fighting Blindness Clinical Research Institute.
Mr. Manning serves as Director at PBM Pharmaceuticals, Inc. Mr. Manning serves as Independent Director at ArcherDX LLC since 2015.
Mr. Manning serves as Director at Tolerion, Inc. Mr. Manning serves as Director at UVA Health Foundation.
Mr. Manning serves as Independent Director at Liquidia Corp.
since 2020.
Former positions include Chairman at Dova Pharmaceuticals, Inc. from 2017 to 2019.
Director at QIAGEN Beverly LLC.
Director at Gen9, Inc. Director at Advanz Pharma Corp.
Ltd. from 2014 to 2015.
Independent Director at Novartis Gene Therapies, Inc. from 2014 to 2018.
Independent Director at Taysha Gene Therapies, Inc. from 2020 to 2023.
Director at Liquidia PAH LLC from 2018 to 2020.
Executive Vice President & General Manager at Perrigo Co. from 2010 to 2014.
Principal at Beta-Pro LLC.
Education includes an undergraduate degree from the University of Massachusetts.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LIQUIDIA CORPORATION 6.42% | 2026-06-03 | 5,711,355 ( 6.42% ) | 353 M $ | 2026-05-30 |
| 2026-03-30 | 22,737,407 ( 8.33% ) | 133 M $ | 2026-05-30 | |
| 2026-04-23 | 5,748,279 ( 7.85% ) | 48 M $ | 2026-05-30 | |
| 2025-11-24 | 4,558,183 ( 26.53% ) | 26 M $ | 2026-05-30 |
Paul Manning active positions
| Companies | Position | Start |
|---|---|---|
| VERRICA PHARMACEUTICALS INC. | Chairman | 2017-11-30 |
| LIQUIDIA CORPORATION | Director/Board Member | 2020-11-17 |
| CANDEL THERAPEUTICS, INC. | Chairman | 2021-07-14 |
PatientsLikeMe LLC
 PatientsLikeMe LLC Packaged SoftwareTechnology Services Operates online health communities for patients | Director/Board Member | 2022-01-18 |
Xalud Therapeutics, Inc.
 Xalud Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company advancing a non-viral plasmid DNA delivered gene therapy platform to treat pathologic inflammation | Chairman | - |
Tolerion, Inc.
 Tolerion, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics | Director/Board Member | - |
ArcherDX LLC
 ArcherDX LLC Packaged SoftwareTechnology Services Develops software solutions for investigating cancer treatment | Director/Board Member | 2014-12-31 |
PBM Pharmaceuticals, Inc.
 PBM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Board Member | - |
The Foundation Fighting Blindness, Inc.
 The Foundation Fighting Blindness, Inc. Miscellaneous Commercial ServicesCommercial Services Provides preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration and usher syndrome | Director/Board Member | - |
| ░░░ ░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Former positions of Paul Manning
| Companies | Position | End |
|---|---|---|
| ░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Paul Manning
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
57
1st degree connections
25
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 25 |
|---|---|
Able Laboratories, Inc.
 Able Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Perrigo Co.
 Perrigo Co. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets pharmaceutical and nutritional products | Health Technology |
QIAGEN Beverly LLC
 QIAGEN Beverly LLC BiotechnologyHealth Technology Manufactures enzymes and biological reagents | Health Technology |
PatientsLikeMe LLC
PatientsLikeMe LLC Packaged SoftwareTechnology Services Operates online health communities for patients | Technology Services |
Gen9, Inc.
 Gen9, Inc. BiotechnologyHealth Technology Develops synthetic biology technologies | Health Technology |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PBM Products LLC
 PBM Products LLC Food: Meat/Fish/DairyConsumer Non-Durables Markets and distributes nutritional and pharmaceutical products | Consumer Non-Durables |
The Foundation Fighting Blindness, Inc.
The Foundation Fighting Blindness, Inc. Miscellaneous Commercial ServicesCommercial Services Provides preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration and usher syndrome | Commercial Services |
Foundation Fighting Blindness Clinical Research Institute
 Foundation Fighting Blindness Clinical Research Institute Financial ConglomeratesFinance Provides investment services | Finance |
Beta-Pro LLC | |
PBM Capital Group LLC
 PBM Capital Group LLC Investment ManagersFinance PBM Capital Group invests in companies located in the United States. The firm targets companies operating in the fields of pharmaceutical and life sciences industries. They provide financing for buyout and early stage capital requirements. | Finance |
Candel Therapeutics, Inc.
 Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
PBM Pharmaceuticals, Inc.
PBM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
ArcherDX LLC
ArcherDX LLC Packaged SoftwareTechnology Services Develops software solutions for investigating cancer treatment | Technology Services |
Advanz Pharma Corp. Ltd.
 Advanz Pharma Corp. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Tolerion, Inc.
Tolerion, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics | Health Technology |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
Xalud Therapeutics, Inc.
Xalud Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company advancing a non-viral plasmid DNA delivered gene therapy platform to treat pathologic inflammation | Health Technology |
Verrica Pharmaceuticals, Inc.
 Verrica Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Pbm Capital Investments LLC | |
UVA Health Foundation
 UVA Health Foundation Internet Software/ServicesTechnology Services Operates a healthcare platform | Technology Services |
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
Taysha Gene Therapies, Inc.
 Taysha Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes adeno-associated viruses-based gene therapies for the treatment of monogenic diseases of the central nervous system | Health Technology |
RareGen LLC
 RareGen LLC Miscellaneous Commercial ServicesCommercial Services Provides investment and commercialization for rare disease pharmaceutical products | Commercial Services |
Liquidia Corp.
 Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Paul Manning
